[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fDBx1xrYwWjR6Zx7ugkVHQ7gNKuip70IpUQktIvx3SYs":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":68,"rows":75},"Samuel Lunenfeld Research Institute, Mount Sinai Hospital",[4],133,false,14,3,10459,11,64,[14,17,20,23,26,29,32,34],{"name":15,"count":16},"Postpartum Hemorrhage",29,{"name":18,"count":19},"Labor Pain",21,{"name":21,"count":22},"Pain",16,{"name":24,"count":25},"Pregnancy",12,{"name":27,"count":28},"Hypotension",7,{"name":30,"count":31},"Obesity",4,{"name":33,"count":9},"Postpartum Hemorrhage (Primary)",{"name":35,"count":9},"Well-Being, Psychological",[37,42,46,50,54,58,61,65],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT06930391","Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium","2026-06","Oxytocin",{"nctId":43,"briefTitle":44,"date":45,"intervention":41},"NCT05290129","Oxytocin Maintenance Infusion in Labouring Women Undergoing Cesarean Delivery: an Up-down Sequential Allocation Study","2026-12",{"nctId":47,"briefTitle":48,"date":45,"intervention":49},"NCT04053478","Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study","Ephedrine",{"nctId":51,"briefTitle":52,"date":45,"intervention":53},"NCT06285409","Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium","Carbetocin",{"nctId":55,"briefTitle":56,"date":45,"intervention":57},"NCT06572241","Quality of Labour Epidural Analgesia With Intrathecal Morphine as a Component of Combined Spinal Epidural","Intrathecal morphine",{"nctId":59,"briefTitle":60,"date":45,"intervention":49},"NCT06285396","Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study",{"nctId":62,"briefTitle":63,"date":45,"intervention":64},"NCT07187544","Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery","Calcium Chloride",{"nctId":66,"briefTitle":67,"date":45,"intervention":41},"NCT06333340","Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery",[69,70,71,72,73,74],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[76,332,437,491,526,548,575,601,623,656,674,692,715,740,765,790,814,832,900,932,961,992,1028,1059,1089,1116,1134,1152,1170,1188,1206,1224,1242,1260,1278,1296,1321,1344,1367,1390,1408,1426,1444,1462,1480,1498,1522,1540,1563,1590,1608,1626,1650,1676],{"intervention":41,"totalTrials":77,"cells":78},25,{"EARLY_PHASE1":79,"PHASE1":82,"PHASE2":84,"PHASE3":86,"PHASE4":88,"NA":90},{"trials":80,"activeCount":81},[],0,{"trials":83,"activeCount":81},[],{"trials":85,"activeCount":81},[],{"trials":87,"activeCount":81},[],{"trials":89,"activeCount":81},[],{"trials":91,"activeCount":331,"soonestReadout":40},[92,105,114,121,127,137,149,160,172,181,192,198,207,215,226,235,244,256,267,276,282,292,301,311,320],{"nctId":93,"briefTitle":94,"status":95,"phases":96,"primaryCompletion":97,"completion":98,"start":99,"enrollment":100,"conditions":101,"interventions":102},"NCT01869556","Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress","COMPLETED",[74],"2019-07-08","2019-09-30","2013-06-04",105,[15],[41,103,104],"Ergot","Carboprost",{"nctId":106,"briefTitle":107,"status":95,"phases":108,"primaryCompletion":109,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":113},"NCT01865669","In-vitro Myometrial Contractility After Oxytocin Pre-exposure in Women With Advanced Maternal Age and Morbid Obesity",[74],"2017-06-13","2013-05",44,[15],[41],{"nctId":43,"briefTitle":44,"status":115,"phases":116,"primaryCompletion":45,"completion":45,"start":117,"enrollment":118,"conditions":119,"interventions":120},"RECRUITING",[74],"2022-08-17",40,[15],[41],{"nctId":38,"briefTitle":39,"status":115,"phases":122,"primaryCompletion":40,"completion":40,"start":123,"enrollment":118,"conditions":124,"interventions":125},[74],"2025-09-15",[33],[41,53,126],"Calcium",{"nctId":128,"briefTitle":129,"status":95,"phases":130,"primaryCompletion":131,"completion":132,"start":133,"enrollment":134,"conditions":135,"interventions":136},"NCT03168698","Carbetocin vs. Oxytocin at Elective Cesarean Section",[74],"2020-12-17","2020-12-18","2017-05-25",278,[15],[53,41],{"nctId":138,"briefTitle":139,"status":95,"phases":140,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":145},"NCT00989027","Impact of Uterotonic Agents on Isolated Human Myometrium",[74],"2013-08","2007-06",56,[15],[41,146,104,147,148],"Ergonovine","Oxytocin and Ergonovine","Oxytocin and Carboprost",{"nctId":150,"briefTitle":151,"status":95,"phases":152,"primaryCompletion":153,"completion":154,"start":155,"enrollment":156,"conditions":157,"interventions":158},"NCT05511415","In Vitro Evaluation of Spontaneous and Oxytocin-induced Contractility of Pregnant Human Myometrium During Exposure to Dexmedetomidine",[74],"2024-11-21","2024-11-22","2022-11-02",50,[15],[41,159],"Dexmedetomidine",{"nctId":161,"briefTitle":162,"status":95,"phases":163,"primaryCompletion":164,"completion":165,"start":166,"enrollment":167,"conditions":168,"interventions":169},"NCT01689311","In Vitro Myometrial Contractions in Laboring and Non-laboring Women",[74],"2011-08","2012-08","2009-03",53,[15],[41,146,170,171],"Prostaglandin F2alpha","Misoprostol",{"nctId":173,"briefTitle":174,"status":95,"phases":175,"primaryCompletion":176,"completion":176,"start":177,"enrollment":178,"conditions":179,"interventions":180},"NCT02051231","Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization",[74],"2014-06","2013-12",22,[15],[41],{"nctId":182,"briefTitle":183,"status":95,"phases":184,"primaryCompletion":185,"completion":186,"start":187,"enrollment":188,"conditions":189,"interventions":191},"NCT04025658","Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy",[74],"2021-09-07","2021-09-08","2019-08-06",30,[15,190],"Twin",[41],{"nctId":51,"briefTitle":52,"status":115,"phases":193,"primaryCompletion":45,"completion":45,"start":194,"enrollment":195,"conditions":196,"interventions":197},[74],"2024-04-04",32,[15],[53,41,53,41,146,104],{"nctId":199,"briefTitle":200,"status":95,"phases":201,"primaryCompletion":202,"completion":202,"start":203,"enrollment":204,"conditions":205,"interventions":206},"NCT02338089","Investigating the Effect of Pulsatile Administration of Oxytocin on the Desensitization of Human Myometrium In-vitro",[74],"2015-06","2015-01",18,[15],[41],{"nctId":59,"briefTitle":60,"status":115,"phases":208,"primaryCompletion":45,"completion":45,"start":209,"enrollment":210,"conditions":211,"interventions":212},[74],"2024-03-18",96,[15],[49,213,214,41],"Phenylephrine","Norepinephrine",{"nctId":216,"briefTitle":217,"status":95,"phases":218,"primaryCompletion":219,"completion":220,"start":221,"enrollment":222,"conditions":223,"interventions":224},"NCT03434444","In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol",[74],"2022-08-19","2022-08-20","2017-09-08",57,[15],[41,225],"Propranolol",{"nctId":227,"briefTitle":228,"status":95,"phases":229,"primaryCompletion":230,"completion":165,"start":231,"enrollment":232,"conditions":233,"interventions":234},"NCT01689298","Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment",[74],"2012-03","2010-01",20,[15],[41,53],{"nctId":236,"briefTitle":237,"status":95,"phases":238,"primaryCompletion":239,"completion":240,"start":241,"enrollment":188,"conditions":242,"interventions":243},"NCT03957083","Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg\u002Fm2",[74],"2020-02-03","2020-02-04","2019-06-26",[15,30],[41],{"nctId":245,"briefTitle":246,"status":95,"phases":247,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":251,"interventions":252},"NCT03852797","Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium",[74],"2022-01-19","2019-03-28",33,[15],[41,253,254,255],"Ketamine","Propofol","Etomidate",{"nctId":257,"briefTitle":258,"status":95,"phases":259,"primaryCompletion":260,"completion":261,"start":262,"enrollment":263,"conditions":264,"interventions":266},"NCT04902729","Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity",[74],"2022-12-08","2022-12-09","2021-07-20",48,[265],"Post Partum Hemorrhage",[53,41],{"nctId":268,"briefTitle":269,"status":95,"phases":270,"primaryCompletion":271,"completion":272,"start":273,"enrollment":118,"conditions":274,"interventions":275},"NCT04946006","Maintenance Infusion of Oxytocin Following Elective Cesarean Deliveries",[74],"2022-04-01","2022-04-02","2021-07-26",[15],[41],{"nctId":66,"briefTitle":67,"status":115,"phases":277,"primaryCompletion":45,"completion":45,"start":278,"enrollment":279,"conditions":280,"interventions":281},[74],"2025-01-14",160,[265],[41,53],{"nctId":283,"briefTitle":284,"status":95,"phases":285,"primaryCompletion":286,"completion":286,"start":287,"enrollment":288,"conditions":289,"interventions":290},"NCT03408054","The Relaxant Effect of Nitroglycerin on Oxytocin Desensitized Human Myometrium",[74],"2018-04-13","2018-01-03",17,[15],[41,291],"Nitroglycerin",{"nctId":293,"briefTitle":294,"status":295,"phases":296,"primaryCompletion":297,"completion":297,"start":298,"enrollment":31,"conditions":299,"interventions":300},"NCT02762669","Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization: an In-vitro Analysis of Oxytocin Receptor Expression and Signaling","TERMINATED",[74],"2023-12-31","2016-08-03",[15],[41],{"nctId":302,"briefTitle":303,"status":95,"phases":304,"primaryCompletion":305,"completion":305,"start":306,"enrollment":307,"conditions":308,"interventions":309},"NCT02647268","Effect of Magnesium Sulphate Pre-exposure on Oxytocin-induced Contractility in Desensitized Human Myometrium - an in Vitro Study",[74],"2017-04","2016-01",26,[15],[41,310],"Magnesium Sulphate",{"nctId":312,"briefTitle":313,"status":95,"phases":314,"primaryCompletion":315,"completion":315,"start":316,"enrollment":317,"conditions":318,"interventions":319},"NCT02274454","Investigating the Effect of Extracellular Calcium on Oxytocin-induced Human Myometrial Contractility In-vitro",[74],"2015-03","2014-11",41,[15],[41,126],{"nctId":321,"briefTitle":322,"status":95,"phases":323,"completion":324,"start":325,"enrollment":326,"conditions":327,"interventions":329},"NCT00481533","Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in Labour",[74],"2007-01","2005-06",47,[328],"Blood Loss, Surgical",[330,41],"Methyl-Ergonovine-Oxytocin",5,{"intervention":53,"totalTrials":8,"cells":333},{"EARLY_PHASE1":334,"PHASE1":336,"PHASE2":338,"PHASE3":340,"PHASE4":342,"NA":344},{"trials":335,"activeCount":81},[],{"trials":337,"activeCount":81},[],{"trials":339,"activeCount":81},[],{"trials":341,"activeCount":81},[],{"trials":343,"activeCount":81},[],{"trials":345,"activeCount":31,"soonestReadout":40},[346,355,365,369,373,382,389,393,397,406,411,415,419,428],{"nctId":347,"briefTitle":348,"status":95,"phases":349,"primaryCompletion":350,"completion":350,"start":351,"enrollment":352,"conditions":353,"interventions":354},"NCT01262742","Carbetocin at Elective Cesarean Delivery",[74],"2011-03","2010-11",80,[15],[53,53,53,53,53],{"nctId":356,"briefTitle":357,"status":95,"phases":358,"primaryCompletion":359,"completion":360,"start":361,"enrollment":362,"conditions":363,"interventions":364},"NCT02264769","Carbetocin at Elective Cesarean Delivery Part 4",[74],"2015-04","2015-05","2014-10",110,[15],[53],{"nctId":38,"briefTitle":39,"status":115,"phases":366,"primaryCompletion":40,"completion":40,"start":123,"enrollment":118,"conditions":367,"interventions":368},[74],[33],[41,53,126],{"nctId":128,"briefTitle":129,"status":95,"phases":370,"primaryCompletion":131,"completion":132,"start":133,"enrollment":134,"conditions":371,"interventions":372},[74],[15],[53,41],{"nctId":374,"briefTitle":375,"status":95,"phases":376,"primaryCompletion":377,"completion":377,"start":378,"enrollment":379,"conditions":380,"interventions":381},"NCT01428817","Carbetocin at Elective Cesarean Delivery Part 2",[74],"2011-12","2011-06",120,[15],[53,53,53,53,53],{"nctId":383,"briefTitle":384,"status":95,"phases":385,"primaryCompletion":165,"completion":165,"start":386,"enrollment":118,"conditions":387,"interventions":388},"NCT01651130","Carbetocin at Elective Cesarean Delivery Part 3",[74],"2012-06",[15],[53],{"nctId":51,"briefTitle":52,"status":115,"phases":390,"primaryCompletion":45,"completion":45,"start":194,"enrollment":195,"conditions":391,"interventions":392},[74],[15],[53,41,53,41,146,104],{"nctId":227,"briefTitle":228,"status":95,"phases":394,"primaryCompletion":230,"completion":165,"start":231,"enrollment":232,"conditions":395,"interventions":396},[74],[15],[41,53],{"nctId":398,"briefTitle":399,"status":95,"phases":400,"primaryCompletion":401,"completion":402,"start":403,"enrollment":188,"conditions":404,"interventions":405},"NCT04182360","Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.",[74],"2023-04-27","2023-04-28","2021-10-14",[15,190],[53],{"nctId":62,"briefTitle":63,"status":115,"phases":407,"primaryCompletion":45,"completion":45,"start":408,"enrollment":379,"conditions":409,"interventions":410},[74],"2025-12-01",[33],[64,53],{"nctId":257,"briefTitle":258,"status":95,"phases":412,"primaryCompletion":260,"completion":261,"start":262,"enrollment":263,"conditions":413,"interventions":414},[74],[265],[53,41],{"nctId":66,"briefTitle":67,"status":115,"phases":416,"primaryCompletion":45,"completion":45,"start":278,"enrollment":279,"conditions":417,"interventions":418},[74],[265],[41,53],{"nctId":420,"briefTitle":421,"status":95,"phases":422,"primaryCompletion":423,"completion":424,"start":425,"enrollment":118,"conditions":426,"interventions":427},"NCT01725243","Carbetocin at Cesarean Delivery for Labor Arrest",[74],"2013-03","2013-04","2012-11",[15],[53],{"nctId":429,"briefTitle":430,"status":95,"phases":431,"primaryCompletion":432,"completion":433,"start":434,"enrollment":188,"conditions":435,"interventions":436},"NCT03672045","Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg\u002Fm2",[74],"2019-05-16","2019-05-17","2018-11-19",[15],[53],{"intervention":213,"totalTrials":331,"cells":438},{"EARLY_PHASE1":439,"PHASE1":441,"PHASE2":443,"PHASE3":445,"PHASE4":447,"NA":460},{"trials":440,"activeCount":81},[],{"trials":442,"activeCount":81},[],{"trials":444,"activeCount":81},[],{"trials":446,"activeCount":81},[],{"trials":448,"activeCount":81},[449],{"nctId":450,"briefTitle":451,"status":95,"phases":452,"primaryCompletion":453,"completion":453,"start":454,"enrollment":455,"conditions":456,"interventions":459},"NCT00996190","Best Regimen for Phenylephrine Administration During Cesarean Section",[73],"2010-08","2009-11",60,[457,458,27],"Cesarean Section","Cardiac Output",[213],{"trials":461,"activeCount":490,"soonestReadout":45},[462,472,480,486],{"nctId":463,"briefTitle":464,"status":95,"phases":465,"completion":466,"start":467,"enrollment":156,"conditions":468,"interventions":470},"NCT00379691","Ideal Dose of Phenylephrine to Treat Low Blood Pressure During Cesarean Section",[74],"2006-12","2006-08",[27,469],"Nausea",[471],"phenylephrine",{"nctId":473,"briefTitle":474,"status":95,"phases":475,"primaryCompletion":305,"completion":305,"start":476,"enrollment":477,"conditions":478,"interventions":479},"NCT02962986","A Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent Spinal-induced Hypotension in Cesarean Deliveries",[74],"2017-01",112,[27],[214,213],{"nctId":47,"briefTitle":48,"status":115,"phases":481,"primaryCompletion":45,"completion":45,"start":97,"enrollment":482,"conditions":483,"interventions":484},[74],144,[27],[49,213,214,485],"Vasopressin",{"nctId":59,"briefTitle":60,"status":115,"phases":487,"primaryCompletion":45,"completion":45,"start":209,"enrollment":210,"conditions":488,"interventions":489},[74],[15],[49,213,214,41],2,{"intervention":214,"totalTrials":31,"cells":492},{"EARLY_PHASE1":493,"PHASE1":495,"PHASE2":497,"PHASE3":499,"PHASE4":501,"NA":503},{"trials":494,"activeCount":81},[],{"trials":496,"activeCount":81},[],{"trials":498,"activeCount":81},[],{"trials":500,"activeCount":81},[],{"trials":502,"activeCount":81},[],{"trials":504,"activeCount":490,"soonestReadout":45},[505,514,518,522],{"nctId":506,"briefTitle":507,"status":95,"phases":508,"primaryCompletion":509,"completion":510,"start":306,"enrollment":118,"conditions":511,"interventions":512},"NCT02654847","Norepinephrine To Prevent Hypotension After Spinal Anesthesia For Cesarean Delivery: A Dose Finding Study",[74],"2016-03","2016-04",[27],[214,513],"Normal Saline",{"nctId":473,"briefTitle":474,"status":95,"phases":515,"primaryCompletion":305,"completion":305,"start":476,"enrollment":477,"conditions":516,"interventions":517},[74],[27],[214,213],{"nctId":47,"briefTitle":48,"status":115,"phases":519,"primaryCompletion":45,"completion":45,"start":97,"enrollment":482,"conditions":520,"interventions":521},[74],[27],[49,213,214,485],{"nctId":59,"briefTitle":60,"status":115,"phases":523,"primaryCompletion":45,"completion":45,"start":209,"enrollment":210,"conditions":524,"interventions":525},[74],[15],[49,213,214,41],{"intervention":49,"totalTrials":490,"cells":527},{"EARLY_PHASE1":528,"PHASE1":530,"PHASE2":532,"PHASE3":534,"PHASE4":536,"NA":538},{"trials":529,"activeCount":81},[],{"trials":531,"activeCount":81},[],{"trials":533,"activeCount":81},[],{"trials":535,"activeCount":81},[],{"trials":537,"activeCount":81},[],{"trials":539,"activeCount":490,"soonestReadout":45},[540,544],{"nctId":47,"briefTitle":48,"status":115,"phases":541,"primaryCompletion":45,"completion":45,"start":97,"enrollment":482,"conditions":542,"interventions":543},[74],[27],[49,213,214,485],{"nctId":59,"briefTitle":60,"status":115,"phases":545,"primaryCompletion":45,"completion":45,"start":209,"enrollment":210,"conditions":546,"interventions":547},[74],[15],[49,213,214,41],{"intervention":104,"totalTrials":9,"cells":549},{"EARLY_PHASE1":550,"PHASE1":552,"PHASE2":554,"PHASE3":556,"PHASE4":558,"NA":560},{"trials":551,"activeCount":81},[],{"trials":553,"activeCount":81},[],{"trials":555,"activeCount":81},[],{"trials":557,"activeCount":81},[],{"trials":559,"activeCount":81},[],{"trials":561,"activeCount":574,"soonestReadout":45},[562,566,570],{"nctId":93,"briefTitle":94,"status":95,"phases":563,"primaryCompletion":97,"completion":98,"start":99,"enrollment":100,"conditions":564,"interventions":565},[74],[15],[41,103,104],{"nctId":138,"briefTitle":139,"status":95,"phases":567,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":568,"interventions":569},[74],[15],[41,146,104,147,148],{"nctId":51,"briefTitle":52,"status":115,"phases":571,"primaryCompletion":45,"completion":45,"start":194,"enrollment":195,"conditions":572,"interventions":573},[74],[15],[53,41,53,41,146,104],1,{"intervention":146,"totalTrials":9,"cells":576},{"EARLY_PHASE1":577,"PHASE1":579,"PHASE2":581,"PHASE3":583,"PHASE4":585,"NA":587},{"trials":578,"activeCount":81},[],{"trials":580,"activeCount":81},[],{"trials":582,"activeCount":81},[],{"trials":584,"activeCount":81},[],{"trials":586,"activeCount":81},[],{"trials":588,"activeCount":574,"soonestReadout":45},[589,593,597],{"nctId":138,"briefTitle":139,"status":95,"phases":590,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":591,"interventions":592},[74],[15],[41,146,104,147,148],{"nctId":161,"briefTitle":162,"status":95,"phases":594,"primaryCompletion":164,"completion":165,"start":166,"enrollment":167,"conditions":595,"interventions":596},[74],[15],[41,146,170,171],{"nctId":51,"briefTitle":52,"status":115,"phases":598,"primaryCompletion":45,"completion":45,"start":194,"enrollment":195,"conditions":599,"interventions":600},[74],[15],[53,41,53,41,146,104],{"intervention":126,"totalTrials":490,"cells":602},{"EARLY_PHASE1":603,"PHASE1":605,"PHASE2":607,"PHASE3":609,"PHASE4":611,"NA":613},{"trials":604,"activeCount":81},[],{"trials":606,"activeCount":81},[],{"trials":608,"activeCount":81},[],{"trials":610,"activeCount":81},[],{"trials":612,"activeCount":81},[],{"trials":614,"activeCount":574,"soonestReadout":40},[615,619],{"nctId":38,"briefTitle":39,"status":115,"phases":616,"primaryCompletion":40,"completion":40,"start":123,"enrollment":118,"conditions":617,"interventions":618},[74],[33],[41,53,126],{"nctId":312,"briefTitle":313,"status":95,"phases":620,"primaryCompletion":315,"completion":315,"start":316,"enrollment":317,"conditions":621,"interventions":622},[74],[15],[41,126],{"intervention":624,"totalTrials":490,"cells":625},"Intrathecal Morphine",{"EARLY_PHASE1":626,"PHASE1":628,"PHASE2":630,"PHASE3":632,"PHASE4":634,"NA":636},{"trials":627,"activeCount":81},[],{"trials":629,"activeCount":81},[],{"trials":631,"activeCount":81},[],{"trials":633,"activeCount":81},[],{"trials":635,"activeCount":81},[],{"trials":637,"activeCount":574,"soonestReadout":45},[638,650],{"nctId":639,"briefTitle":640,"status":95,"phases":641,"primaryCompletion":642,"completion":643,"start":644,"enrollment":645,"conditions":646,"interventions":649},"NCT05105074","Does the Use of Intrathecal Morphine Increase the Length of Hospital Stay in Fast Track Orthopedic Procedures?",[74],"2021-10-01","2021-10-30","2019-01-19",104,[647,648],"Arthropathy of Knee","Arthropathy of Hip",[624],{"nctId":55,"briefTitle":56,"status":115,"phases":651,"primaryCompletion":45,"completion":45,"start":652,"enrollment":653,"conditions":654,"interventions":655},[74],"2024-11-20",182,[18],[57],{"intervention":485,"totalTrials":574,"cells":657},{"EARLY_PHASE1":658,"PHASE1":660,"PHASE2":662,"PHASE3":664,"PHASE4":666,"NA":668},{"trials":659,"activeCount":81},[],{"trials":661,"activeCount":81},[],{"trials":663,"activeCount":81},[],{"trials":665,"activeCount":81},[],{"trials":667,"activeCount":81},[],{"trials":669,"activeCount":574,"soonestReadout":45},[670],{"nctId":47,"briefTitle":48,"status":115,"phases":671,"primaryCompletion":45,"completion":45,"start":97,"enrollment":482,"conditions":672,"interventions":673},[74],[27],[49,213,214,485],{"intervention":64,"totalTrials":574,"cells":675},{"EARLY_PHASE1":676,"PHASE1":678,"PHASE2":680,"PHASE3":682,"PHASE4":684,"NA":686},{"trials":677,"activeCount":81},[],{"trials":679,"activeCount":81},[],{"trials":681,"activeCount":81},[],{"trials":683,"activeCount":81},[],{"trials":685,"activeCount":81},[],{"trials":687,"activeCount":574,"soonestReadout":45},[688],{"nctId":62,"briefTitle":63,"status":115,"phases":689,"primaryCompletion":45,"completion":45,"start":408,"enrollment":379,"conditions":690,"interventions":691},[74],[33],[64,53],{"intervention":693,"totalTrials":574,"cells":694},"Medroxyprogesterone acetate",{"EARLY_PHASE1":695,"PHASE1":697,"PHASE2":699,"PHASE3":701,"PHASE4":703,"NA":713},{"trials":696,"activeCount":81},[],{"trials":698,"activeCount":81},[],{"trials":700,"activeCount":81},[],{"trials":702,"activeCount":81},[],{"trials":704,"activeCount":81},[705],{"nctId":706,"briefTitle":707,"status":95,"phases":708,"primaryCompletion":359,"completion":359,"start":709,"enrollment":156,"conditions":710,"interventions":712},"NCT02340013","Endometrial Shedding Prior to Ovulation Induction Pilot Study",[73],"2013-07",[711],"Infertility",[693],{"trials":714,"activeCount":81},[],{"intervention":716,"totalTrials":574,"cells":717},"empagliflozin",{"EARLY_PHASE1":718,"PHASE1":720,"PHASE2":722,"PHASE3":724,"PHASE4":736,"NA":738},{"trials":719,"activeCount":81},[],{"trials":721,"activeCount":81},[],{"trials":723,"activeCount":81},[],{"trials":725,"activeCount":81},[726],{"nctId":727,"briefTitle":728,"status":95,"phases":729,"primaryCompletion":730,"completion":730,"start":731,"enrollment":732,"conditions":733,"interventions":735},"NCT03979352","Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting",[72],"2021-08-31","2019-08-01",28,[734],"Type1 Diabetes Mellitus",[716],{"trials":737,"activeCount":81},[],{"trials":739,"activeCount":81},[],{"intervention":741,"totalTrials":574,"cells":742},"Avandamet [Rosiglitazone 2mg\u002FMetformin 500mg] BID",{"EARLY_PHASE1":743,"PHASE1":745,"PHASE2":747,"PHASE3":749,"PHASE4":761,"NA":763},{"trials":744,"activeCount":81},[],{"trials":746,"activeCount":81},[],{"trials":748,"activeCount":81},[],{"trials":750,"activeCount":81},[751],{"nctId":752,"briefTitle":753,"status":95,"phases":754,"primaryCompletion":231,"completion":231,"start":755,"enrollment":756,"conditions":757,"interventions":760},"NCT00116922","A Lifestyle and Combination Medication Therapy Diabetes Prevention Study",[72],"2004-06",207,[758,759],"Impaired Glucose Tolerance","Diabetes",[741],{"trials":762,"activeCount":81},[],{"trials":764,"activeCount":81},[],{"intervention":766,"totalTrials":574,"cells":767},"Oral Prednisone",{"EARLY_PHASE1":768,"PHASE1":770,"PHASE2":772,"PHASE3":774,"PHASE4":786,"NA":788},{"trials":769,"activeCount":81},[],{"trials":771,"activeCount":81},[],{"trials":773,"activeCount":81},[],{"trials":775,"activeCount":81},[776],{"nctId":777,"briefTitle":778,"status":95,"phases":779,"primaryCompletion":780,"completion":781,"start":351,"enrollment":782,"conditions":783,"interventions":785},"NCT00440219","The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy.",[72],"2012-12","2013-06",34,[784],"Nasal Polyps",[766],{"trials":787,"activeCount":81},[],{"trials":789,"activeCount":81},[],{"intervention":791,"totalTrials":574,"cells":792},"Sitagliptin",{"EARLY_PHASE1":793,"PHASE1":795,"PHASE2":797,"PHASE3":808,"PHASE4":810,"NA":812},{"trials":794,"activeCount":81},[],{"trials":796,"activeCount":81},[],{"trials":798,"activeCount":81},[799],{"nctId":800,"briefTitle":801,"status":95,"phases":802,"primaryCompletion":803,"completion":803,"start":324,"enrollment":19,"conditions":804,"interventions":806},"NCT00420511","Beta-Cell Function and Sitagliptin Trial (BEST)",[71],"2009-09",[805],"Type 2 Diabetes Mellitus",[791,807],"metformin",{"trials":809,"activeCount":81},[],{"trials":811,"activeCount":81},[],{"trials":813,"activeCount":81},[],{"intervention":807,"totalTrials":574,"cells":815},{"EARLY_PHASE1":816,"PHASE1":818,"PHASE2":820,"PHASE3":826,"PHASE4":828,"NA":830},{"trials":817,"activeCount":81},[],{"trials":819,"activeCount":81},[],{"trials":821,"activeCount":81},[822],{"nctId":800,"briefTitle":801,"status":95,"phases":823,"primaryCompletion":803,"completion":803,"start":324,"enrollment":19,"conditions":824,"interventions":825},[71],[805],[791,807],{"trials":827,"activeCount":81},[],{"trials":829,"activeCount":81},[],{"trials":831,"activeCount":81},[],{"intervention":833,"totalTrials":834,"cells":835},"Bupivacaine",6,{"EARLY_PHASE1":836,"PHASE1":838,"PHASE2":840,"PHASE3":842,"PHASE4":844,"NA":846},{"trials":837,"activeCount":81},[],{"trials":839,"activeCount":81},[],{"trials":841,"activeCount":81},[],{"trials":843,"activeCount":81},[],{"trials":845,"activeCount":81},[],{"trials":847,"activeCount":81},[848,857,865,873,880,890],{"nctId":849,"briefTitle":850,"status":95,"phases":851,"primaryCompletion":852,"completion":852,"start":853,"enrollment":118,"conditions":854,"interventions":855},"NCT02758405","Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor 2",[74],"2017-02","2016-05",[18],[833,856],"Fentanyl",{"nctId":858,"briefTitle":859,"status":95,"phases":860,"primaryCompletion":861,"completion":861,"start":862,"enrollment":118,"conditions":863,"interventions":864},"NCT02550262","Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor",[74],"2015-12","2015-09",[18],[833,856],{"nctId":866,"briefTitle":867,"status":95,"phases":868,"primaryCompletion":869,"completion":869,"start":870,"enrollment":232,"conditions":871,"interventions":872},"NCT03735771","Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 2.5ml of Bupivacaine 0.25% Plus Fentanyl 8 mcg\u002Fml",[74],"2019-11-01","2018-12-03",[18],[833],{"nctId":874,"briefTitle":875,"status":95,"phases":876,"primaryCompletion":476,"completion":476,"start":877,"enrollment":118,"conditions":878,"interventions":879},"NCT02887222","Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor-3",[74],"2016-08",[18],[833],{"nctId":881,"briefTitle":882,"status":95,"phases":883,"primaryCompletion":884,"completion":884,"start":885,"enrollment":886,"conditions":887,"interventions":888},"NCT00808327","Spinal Anesthesia for Cesarean Delivery: Bupivacaine With or Without Fentanyl",[74],"2009-08","2009-01",140,[21],[833,889],"Bupivacaine, fentanyl",{"nctId":891,"briefTitle":892,"status":95,"phases":893,"completion":894,"start":895,"enrollment":156,"conditions":896,"interventions":898},"NCT00450099","Minimum Local Anesthetic Volume of Bupivacaine in Labour Epidurals",[74],"2007-08","2005-10",[897],"Acute Pain",[899],"bupivacaine",{"intervention":856,"totalTrials":9,"cells":901},{"EARLY_PHASE1":902,"PHASE1":904,"PHASE2":906,"PHASE3":908,"PHASE4":910,"NA":912},{"trials":903,"activeCount":81},[],{"trials":905,"activeCount":81},[],{"trials":907,"activeCount":81},[],{"trials":909,"activeCount":81},[],{"trials":911,"activeCount":81},[],{"trials":913,"activeCount":81},[914,918,928],{"nctId":849,"briefTitle":850,"status":95,"phases":915,"primaryCompletion":852,"completion":852,"start":853,"enrollment":118,"conditions":916,"interventions":917},[74],[18],[833,856],{"nctId":919,"briefTitle":920,"status":295,"phases":921,"primaryCompletion":922,"completion":922,"start":230,"enrollment":923,"conditions":924,"interventions":925},"NCT01563835","Analgesia for 2nd Trimester Termination of Pregnancy",[74],"2014-01",42,[21],[926,927],"bupivacaine, fentanyl","fentanyl",{"nctId":858,"briefTitle":859,"status":95,"phases":929,"primaryCompletion":861,"completion":861,"start":862,"enrollment":118,"conditions":930,"interventions":931},[74],[18],[833,856],{"intervention":926,"totalTrials":9,"cells":933},{"EARLY_PHASE1":934,"PHASE1":936,"PHASE2":938,"PHASE3":940,"PHASE4":942,"NA":944},{"trials":935,"activeCount":81},[],{"trials":937,"activeCount":81},[],{"trials":939,"activeCount":81},[],{"trials":941,"activeCount":81},[],{"trials":943,"activeCount":81},[],{"trials":945,"activeCount":81},[946,950,957],{"nctId":919,"briefTitle":920,"status":295,"phases":947,"primaryCompletion":922,"completion":922,"start":230,"enrollment":923,"conditions":948,"interventions":949},[74],[21],[926,927],{"nctId":951,"briefTitle":952,"status":95,"phases":953,"completion":142,"start":324,"enrollment":22,"conditions":954,"interventions":955},"NCT00465231","Preventive Analgesia in Multiparas Undergoing Induction of Labour",[74],[21],[926,956],"preservative free saline",{"nctId":881,"briefTitle":882,"status":95,"phases":958,"primaryCompletion":884,"completion":884,"start":885,"enrollment":886,"conditions":959,"interventions":960},[74],[21],[833,889],{"intervention":513,"totalTrials":490,"cells":962},{"EARLY_PHASE1":963,"PHASE1":965,"PHASE2":967,"PHASE3":969,"PHASE4":971,"NA":973},{"trials":964,"activeCount":81},[],{"trials":966,"activeCount":81},[],{"trials":968,"activeCount":81},[],{"trials":970,"activeCount":81},[],{"trials":972,"activeCount":81},[],{"trials":974,"activeCount":81},[975,979],{"nctId":506,"briefTitle":507,"status":95,"phases":976,"primaryCompletion":509,"completion":510,"start":306,"enrollment":118,"conditions":977,"interventions":978},[74],[27],[214,513],{"nctId":980,"briefTitle":981,"status":95,"phases":982,"primaryCompletion":983,"completion":984,"start":985,"enrollment":986,"conditions":987,"interventions":989},"NCT06230003","Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD)",[74],"2024-12-17","2025-03-01","2021-07-21",67,[988],"Opioid Use",[990,991],"Ropivacaine","normal saline",{"intervention":993,"totalTrials":490,"cells":994},"lactose",{"EARLY_PHASE1":995,"PHASE1":997,"PHASE2":999,"PHASE3":1001,"PHASE4":1003,"NA":1005},{"trials":996,"activeCount":81},[],{"trials":998,"activeCount":81},[],{"trials":1000,"activeCount":81},[],{"trials":1002,"activeCount":81},[],{"trials":1004,"activeCount":81},[],{"trials":1006,"activeCount":81},[1007,1019],{"nctId":1008,"briefTitle":1009,"status":95,"phases":1010,"primaryCompletion":1011,"completion":1012,"start":1013,"enrollment":1014,"conditions":1015,"interventions":1016},"NCT01094925","The Effectiveness of Gabapentin for Post-operative Pain Following Cesarean Section",[74],"2010-12","2011-02","2010-04",126,[21],[993,1017,1018],"Gabapentin 300mg","Gabapentin 600mg",{"nctId":1020,"briefTitle":1021,"status":95,"phases":1022,"primaryCompletion":177,"completion":1023,"start":110,"enrollment":1024,"conditions":1025,"interventions":1026},"NCT01848119","Does a Perioperative Course of Gabapentin Improve Analgesia After Cesarean Delivery?",[74],"2014-02",204,[21],[1027,993],"Gabapentin",{"intervention":1029,"totalTrials":490,"cells":1030},"Lidocaine",{"EARLY_PHASE1":1031,"PHASE1":1033,"PHASE2":1035,"PHASE3":1037,"PHASE4":1039,"NA":1041},{"trials":1032,"activeCount":81},[],{"trials":1034,"activeCount":81},[],{"trials":1036,"activeCount":81},[],{"trials":1038,"activeCount":81},[],{"trials":1040,"activeCount":81},[],{"trials":1042,"activeCount":81},[1043,1052],{"nctId":1044,"briefTitle":1045,"status":95,"phases":1046,"primaryCompletion":1047,"completion":1047,"start":1048,"enrollment":352,"conditions":1049,"interventions":1050},"NCT01972269","Determination of the Effective Volume of 0.125% Bupivacaine-fentanyl 5mcg\u002FmL in Labour Epidurals",[74],"2014-04","2013-10",[21],[1051,1029],"Bupivacaine-fentanyl",{"nctId":1053,"briefTitle":1054,"status":95,"phases":1055,"primaryCompletion":1056,"completion":1056,"start":316,"enrollment":1024,"conditions":1057,"interventions":1058},"NCT02264795","Does Intraperitoneal Instillation of Lidocaine at Cesarean Delivery Improve Postoperative Analgesia?",[74],"2015-11",[21],[1029],{"intervention":990,"totalTrials":490,"cells":1060},{"EARLY_PHASE1":1061,"PHASE1":1063,"PHASE2":1065,"PHASE3":1067,"PHASE4":1069,"NA":1071},{"trials":1062,"activeCount":81},[],{"trials":1064,"activeCount":81},[],{"trials":1066,"activeCount":81},[],{"trials":1068,"activeCount":81},[],{"trials":1070,"activeCount":81},[],{"trials":1072,"activeCount":81},[1073,1077],{"nctId":980,"briefTitle":981,"status":95,"phases":1074,"primaryCompletion":983,"completion":984,"start":985,"enrollment":986,"conditions":1075,"interventions":1076},[74],[988],[990,991],{"nctId":1078,"briefTitle":1079,"status":95,"phases":1080,"primaryCompletion":1081,"completion":1082,"start":1083,"enrollment":1084,"conditions":1085,"interventions":1086},"NCT00573963","Efficacy of the Transversus Abdominus Plane (TAP) Block for Post-Cesarean Delivery Analgesia",[74],"2008-09","2008-11","2007-12",100,[21],[1087,1088],"ropivacaine","saline solution",{"intervention":1027,"totalTrials":490,"cells":1090},{"EARLY_PHASE1":1091,"PHASE1":1093,"PHASE2":1095,"PHASE3":1097,"PHASE4":1099,"NA":1101},{"trials":1092,"activeCount":81},[],{"trials":1094,"activeCount":81},[],{"trials":1096,"activeCount":81},[],{"trials":1098,"activeCount":81},[],{"trials":1100,"activeCount":81},[],{"trials":1102,"activeCount":81},[1103,1107],{"nctId":1020,"briefTitle":1021,"status":95,"phases":1104,"primaryCompletion":177,"completion":1023,"start":110,"enrollment":1024,"conditions":1105,"interventions":1106},[74],[21],[1027,993],{"nctId":1108,"briefTitle":1109,"status":295,"phases":1110,"primaryCompletion":1082,"completion":1111,"start":1112,"enrollment":1113,"conditions":1114,"interventions":1115},"NCT00573664","The Effectiveness and Safety of Gabapentin for Post-operative Pain After Cesarean Section",[74],"2009-02","2007-11",46,[21],[1027],{"intervention":103,"totalTrials":574,"cells":1117},{"EARLY_PHASE1":1118,"PHASE1":1120,"PHASE2":1122,"PHASE3":1124,"PHASE4":1126,"NA":1128},{"trials":1119,"activeCount":81},[],{"trials":1121,"activeCount":81},[],{"trials":1123,"activeCount":81},[],{"trials":1125,"activeCount":81},[],{"trials":1127,"activeCount":81},[],{"trials":1129,"activeCount":81},[1130],{"nctId":93,"briefTitle":94,"status":95,"phases":1131,"primaryCompletion":97,"completion":98,"start":99,"enrollment":100,"conditions":1132,"interventions":1133},[74],[15],[41,103,104],{"intervention":956,"totalTrials":574,"cells":1135},{"EARLY_PHASE1":1136,"PHASE1":1138,"PHASE2":1140,"PHASE3":1142,"PHASE4":1144,"NA":1146},{"trials":1137,"activeCount":81},[],{"trials":1139,"activeCount":81},[],{"trials":1141,"activeCount":81},[],{"trials":1143,"activeCount":81},[],{"trials":1145,"activeCount":81},[],{"trials":1147,"activeCount":81},[1148],{"nctId":951,"briefTitle":952,"status":95,"phases":1149,"completion":142,"start":324,"enrollment":22,"conditions":1150,"interventions":1151},[74],[21],[926,956],{"intervention":147,"totalTrials":574,"cells":1153},{"EARLY_PHASE1":1154,"PHASE1":1156,"PHASE2":1158,"PHASE3":1160,"PHASE4":1162,"NA":1164},{"trials":1155,"activeCount":81},[],{"trials":1157,"activeCount":81},[],{"trials":1159,"activeCount":81},[],{"trials":1161,"activeCount":81},[],{"trials":1163,"activeCount":81},[],{"trials":1165,"activeCount":81},[1166],{"nctId":138,"briefTitle":139,"status":95,"phases":1167,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":1168,"interventions":1169},[74],[15],[41,146,104,147,148],{"intervention":148,"totalTrials":574,"cells":1171},{"EARLY_PHASE1":1172,"PHASE1":1174,"PHASE2":1176,"PHASE3":1178,"PHASE4":1180,"NA":1182},{"trials":1173,"activeCount":81},[],{"trials":1175,"activeCount":81},[],{"trials":1177,"activeCount":81},[],{"trials":1179,"activeCount":81},[],{"trials":1181,"activeCount":81},[],{"trials":1183,"activeCount":81},[1184],{"nctId":138,"briefTitle":139,"status":95,"phases":1185,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":1186,"interventions":1187},[74],[15],[41,146,104,147,148],{"intervention":1017,"totalTrials":574,"cells":1189},{"EARLY_PHASE1":1190,"PHASE1":1192,"PHASE2":1194,"PHASE3":1196,"PHASE4":1198,"NA":1200},{"trials":1191,"activeCount":81},[],{"trials":1193,"activeCount":81},[],{"trials":1195,"activeCount":81},[],{"trials":1197,"activeCount":81},[],{"trials":1199,"activeCount":81},[],{"trials":1201,"activeCount":81},[1202],{"nctId":1008,"briefTitle":1009,"status":95,"phases":1203,"primaryCompletion":1011,"completion":1012,"start":1013,"enrollment":1014,"conditions":1204,"interventions":1205},[74],[21],[993,1017,1018],{"intervention":1018,"totalTrials":574,"cells":1207},{"EARLY_PHASE1":1208,"PHASE1":1210,"PHASE2":1212,"PHASE3":1214,"PHASE4":1216,"NA":1218},{"trials":1209,"activeCount":81},[],{"trials":1211,"activeCount":81},[],{"trials":1213,"activeCount":81},[],{"trials":1215,"activeCount":81},[],{"trials":1217,"activeCount":81},[],{"trials":1219,"activeCount":81},[1220],{"nctId":1008,"briefTitle":1009,"status":95,"phases":1221,"primaryCompletion":1011,"completion":1012,"start":1013,"enrollment":1014,"conditions":1222,"interventions":1223},[74],[21],[993,1017,1018],{"intervention":159,"totalTrials":574,"cells":1225},{"EARLY_PHASE1":1226,"PHASE1":1228,"PHASE2":1230,"PHASE3":1232,"PHASE4":1234,"NA":1236},{"trials":1227,"activeCount":81},[],{"trials":1229,"activeCount":81},[],{"trials":1231,"activeCount":81},[],{"trials":1233,"activeCount":81},[],{"trials":1235,"activeCount":81},[],{"trials":1237,"activeCount":81},[1238],{"nctId":150,"briefTitle":151,"status":95,"phases":1239,"primaryCompletion":153,"completion":154,"start":155,"enrollment":156,"conditions":1240,"interventions":1241},[74],[15],[41,159],{"intervention":1051,"totalTrials":574,"cells":1243},{"EARLY_PHASE1":1244,"PHASE1":1246,"PHASE2":1248,"PHASE3":1250,"PHASE4":1252,"NA":1254},{"trials":1245,"activeCount":81},[],{"trials":1247,"activeCount":81},[],{"trials":1249,"activeCount":81},[],{"trials":1251,"activeCount":81},[],{"trials":1253,"activeCount":81},[],{"trials":1255,"activeCount":81},[1256],{"nctId":1044,"briefTitle":1045,"status":95,"phases":1257,"primaryCompletion":1047,"completion":1047,"start":1048,"enrollment":352,"conditions":1258,"interventions":1259},[74],[21],[1051,1029],{"intervention":170,"totalTrials":574,"cells":1261},{"EARLY_PHASE1":1262,"PHASE1":1264,"PHASE2":1266,"PHASE3":1268,"PHASE4":1270,"NA":1272},{"trials":1263,"activeCount":81},[],{"trials":1265,"activeCount":81},[],{"trials":1267,"activeCount":81},[],{"trials":1269,"activeCount":81},[],{"trials":1271,"activeCount":81},[],{"trials":1273,"activeCount":81},[1274],{"nctId":161,"briefTitle":162,"status":95,"phases":1275,"primaryCompletion":164,"completion":165,"start":166,"enrollment":167,"conditions":1276,"interventions":1277},[74],[15],[41,146,170,171],{"intervention":171,"totalTrials":574,"cells":1279},{"EARLY_PHASE1":1280,"PHASE1":1282,"PHASE2":1284,"PHASE3":1286,"PHASE4":1288,"NA":1290},{"trials":1281,"activeCount":81},[],{"trials":1283,"activeCount":81},[],{"trials":1285,"activeCount":81},[],{"trials":1287,"activeCount":81},[],{"trials":1289,"activeCount":81},[],{"trials":1291,"activeCount":81},[1292],{"nctId":161,"briefTitle":162,"status":95,"phases":1293,"primaryCompletion":164,"completion":165,"start":166,"enrollment":167,"conditions":1294,"interventions":1295},[74],[15],[41,146,170,171],{"intervention":1297,"totalTrials":574,"cells":1298},"Letrozole",{"EARLY_PHASE1":1299,"PHASE1":1301,"PHASE2":1303,"PHASE3":1305,"PHASE4":1307,"NA":1309},{"trials":1300,"activeCount":81},[],{"trials":1302,"activeCount":81},[],{"trials":1304,"activeCount":81},[],{"trials":1306,"activeCount":81},[],{"trials":1308,"activeCount":81},[],{"trials":1310,"activeCount":81},[1311],{"nctId":1312,"briefTitle":1313,"status":95,"phases":1314,"primaryCompletion":1315,"completion":1315,"start":1316,"enrollment":1317,"conditions":1318,"interventions":1320},"NCT01669343","Aromatase Inhibitor Host Factors Study",[74],"2016-12","2012-10",121,[1319],"Breast Neoplasms",[1297],{"intervention":1322,"totalTrials":574,"cells":1323},"bupivacaine 0.75% with fentanyl and morphine",{"EARLY_PHASE1":1324,"PHASE1":1326,"PHASE2":1328,"PHASE3":1330,"PHASE4":1332,"NA":1334},{"trials":1325,"activeCount":81},[],{"trials":1327,"activeCount":81},[],{"trials":1329,"activeCount":81},[],{"trials":1331,"activeCount":81},[],{"trials":1333,"activeCount":81},[],{"trials":1335,"activeCount":81},[1336],{"nctId":1337,"briefTitle":1338,"status":95,"phases":1339,"primaryCompletion":1083,"completion":1083,"start":1340,"enrollment":1341,"conditions":1342,"interventions":1343},"NCT00403663","Effect of Body Mass Index on the Dose of Intrathecal Hyperbaric Bupivacaine for Elective Cesarean Section",[74],"2006-10",52,[21,30],[1322],{"intervention":1345,"totalTrials":574,"cells":1346},"Dimenhydrinate",{"EARLY_PHASE1":1347,"PHASE1":1349,"PHASE2":1351,"PHASE3":1353,"PHASE4":1355,"NA":1357},{"trials":1348,"activeCount":81},[],{"trials":1350,"activeCount":81},[],{"trials":1352,"activeCount":81},[],{"trials":1354,"activeCount":81},[],{"trials":1356,"activeCount":81},[],{"trials":1358,"activeCount":81},[1359],{"nctId":1360,"briefTitle":1361,"status":95,"phases":1362,"primaryCompletion":803,"completion":803,"start":1082,"enrollment":1363,"conditions":1364,"interventions":1366},"NCT00791960","Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting",[74],149,[469,1365],"Vomiting",[1345],{"intervention":1368,"totalTrials":574,"cells":1369},"Remifentanil",{"EARLY_PHASE1":1370,"PHASE1":1372,"PHASE2":1374,"PHASE3":1376,"PHASE4":1378,"NA":1380},{"trials":1371,"activeCount":81},[],{"trials":1373,"activeCount":81},[],{"trials":1375,"activeCount":81},[],{"trials":1377,"activeCount":81},[],{"trials":1379,"activeCount":81},[],{"trials":1381,"activeCount":81},[1382],{"nctId":1383,"briefTitle":1384,"status":295,"phases":1385,"primaryCompletion":1386,"completion":1386,"start":1387,"enrollment":490,"conditions":1388,"interventions":1389},"NCT01563939","Patient-controlled Intravenous Analgesia With Remifentanil Infusion for Labour",[74],"2014-12","2012-02",[21],[1368],{"intervention":225,"totalTrials":574,"cells":1391},{"EARLY_PHASE1":1392,"PHASE1":1394,"PHASE2":1396,"PHASE3":1398,"PHASE4":1400,"NA":1402},{"trials":1393,"activeCount":81},[],{"trials":1395,"activeCount":81},[],{"trials":1397,"activeCount":81},[],{"trials":1399,"activeCount":81},[],{"trials":1401,"activeCount":81},[],{"trials":1403,"activeCount":81},[1404],{"nctId":216,"briefTitle":217,"status":95,"phases":1405,"primaryCompletion":219,"completion":220,"start":221,"enrollment":222,"conditions":1406,"interventions":1407},[74],[15],[41,225],{"intervention":253,"totalTrials":574,"cells":1409},{"EARLY_PHASE1":1410,"PHASE1":1412,"PHASE2":1414,"PHASE3":1416,"PHASE4":1418,"NA":1420},{"trials":1411,"activeCount":81},[],{"trials":1413,"activeCount":81},[],{"trials":1415,"activeCount":81},[],{"trials":1417,"activeCount":81},[],{"trials":1419,"activeCount":81},[],{"trials":1421,"activeCount":81},[1422],{"nctId":245,"briefTitle":246,"status":95,"phases":1423,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":1424,"interventions":1425},[74],[15],[41,253,254,255],{"intervention":254,"totalTrials":574,"cells":1427},{"EARLY_PHASE1":1428,"PHASE1":1430,"PHASE2":1432,"PHASE3":1434,"PHASE4":1436,"NA":1438},{"trials":1429,"activeCount":81},[],{"trials":1431,"activeCount":81},[],{"trials":1433,"activeCount":81},[],{"trials":1435,"activeCount":81},[],{"trials":1437,"activeCount":81},[],{"trials":1439,"activeCount":81},[1440],{"nctId":245,"briefTitle":246,"status":95,"phases":1441,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":1442,"interventions":1443},[74],[15],[41,253,254,255],{"intervention":255,"totalTrials":574,"cells":1445},{"EARLY_PHASE1":1446,"PHASE1":1448,"PHASE2":1450,"PHASE3":1452,"PHASE4":1454,"NA":1456},{"trials":1447,"activeCount":81},[],{"trials":1449,"activeCount":81},[],{"trials":1451,"activeCount":81},[],{"trials":1453,"activeCount":81},[],{"trials":1455,"activeCount":81},[],{"trials":1457,"activeCount":81},[1458],{"nctId":245,"briefTitle":246,"status":95,"phases":1459,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":1460,"interventions":1461},[74],[15],[41,253,254,255],{"intervention":1088,"totalTrials":574,"cells":1463},{"EARLY_PHASE1":1464,"PHASE1":1466,"PHASE2":1468,"PHASE3":1470,"PHASE4":1472,"NA":1474},{"trials":1465,"activeCount":81},[],{"trials":1467,"activeCount":81},[],{"trials":1469,"activeCount":81},[],{"trials":1471,"activeCount":81},[],{"trials":1473,"activeCount":81},[],{"trials":1475,"activeCount":81},[1476],{"nctId":1078,"briefTitle":1079,"status":95,"phases":1477,"primaryCompletion":1081,"completion":1082,"start":1083,"enrollment":1084,"conditions":1478,"interventions":1479},[74],[21],[1087,1088],{"intervention":291,"totalTrials":574,"cells":1481},{"EARLY_PHASE1":1482,"PHASE1":1484,"PHASE2":1486,"PHASE3":1488,"PHASE4":1490,"NA":1492},{"trials":1483,"activeCount":81},[],{"trials":1485,"activeCount":81},[],{"trials":1487,"activeCount":81},[],{"trials":1489,"activeCount":81},[],{"trials":1491,"activeCount":81},[],{"trials":1493,"activeCount":81},[1494],{"nctId":283,"briefTitle":284,"status":95,"phases":1495,"primaryCompletion":286,"completion":286,"start":287,"enrollment":288,"conditions":1496,"interventions":1497},[74],[15],[41,291],{"intervention":1499,"totalTrials":574,"cells":1500},"Spinal Anesthesia",{"EARLY_PHASE1":1501,"PHASE1":1503,"PHASE2":1505,"PHASE3":1507,"PHASE4":1509,"NA":1511},{"trials":1502,"activeCount":81},[],{"trials":1504,"activeCount":81},[],{"trials":1506,"activeCount":81},[],{"trials":1508,"activeCount":81},[],{"trials":1510,"activeCount":81},[],{"trials":1512,"activeCount":81},[1513],{"nctId":1514,"briefTitle":1515,"status":95,"phases":1516,"completion":1517,"start":1518,"enrollment":352,"conditions":1519,"interventions":1521},"NCT00452972","Exteriorized Versus In Situ Uterine Repair at Cesarean Delivery",[74],"2004-12","2004-04",[1365,469,21,27,1520],"Tachycardia",[1499],{"intervention":310,"totalTrials":574,"cells":1523},{"EARLY_PHASE1":1524,"PHASE1":1526,"PHASE2":1528,"PHASE3":1530,"PHASE4":1532,"NA":1534},{"trials":1525,"activeCount":81},[],{"trials":1527,"activeCount":81},[],{"trials":1529,"activeCount":81},[],{"trials":1531,"activeCount":81},[],{"trials":1533,"activeCount":81},[],{"trials":1535,"activeCount":81},[1536],{"nctId":302,"briefTitle":303,"status":95,"phases":1537,"primaryCompletion":305,"completion":305,"start":306,"enrollment":307,"conditions":1538,"interventions":1539},[74],[15],[41,310],{"intervention":1541,"totalTrials":574,"cells":1542},"Nifedipine",{"EARLY_PHASE1":1543,"PHASE1":1545,"PHASE2":1547,"PHASE3":1549,"PHASE4":1551,"NA":1553},{"trials":1544,"activeCount":81},[],{"trials":1546,"activeCount":81},[],{"trials":1548,"activeCount":81},[],{"trials":1550,"activeCount":81},[],{"trials":1552,"activeCount":81},[],{"trials":1554,"activeCount":81},[1555],{"nctId":1556,"briefTitle":1557,"status":95,"phases":1558,"primaryCompletion":425,"completion":425,"start":1011,"enrollment":232,"conditions":1559,"interventions":1562},"NCT01351428","Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia",[74],[1560,24,1561],"Pre-Eclampsia","Hypertension",[1541],{"intervention":1564,"totalTrials":574,"cells":1565},"continuous adductor canal block (CACB) ropivacaine",{"EARLY_PHASE1":1566,"PHASE1":1568,"PHASE2":1570,"PHASE3":1572,"PHASE4":1574,"NA":1576},{"trials":1567,"activeCount":81},[],{"trials":1569,"activeCount":81},[],{"trials":1571,"activeCount":81},[],{"trials":1573,"activeCount":81},[],{"trials":1575,"activeCount":81},[],{"trials":1577,"activeCount":81},[1578],{"nctId":1579,"briefTitle":1580,"status":1581,"phases":1582,"primaryCompletion":1583,"completion":1584,"start":1585,"enrollment":118,"conditions":1586,"interventions":1588},"NCT05962970","Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty","UNKNOWN",[74],"2024-08-03","2024-12-31","2023-10-04",[1587],"Total Knee Arthroplasty",[1564,1589],"sham continuous adductor canal block - ShACB NaCl",{"intervention":1589,"totalTrials":574,"cells":1591},{"EARLY_PHASE1":1592,"PHASE1":1594,"PHASE2":1596,"PHASE3":1598,"PHASE4":1600,"NA":1602},{"trials":1593,"activeCount":81},[],{"trials":1595,"activeCount":81},[],{"trials":1597,"activeCount":81},[],{"trials":1599,"activeCount":81},[],{"trials":1601,"activeCount":81},[],{"trials":1603,"activeCount":81},[1604],{"nctId":1579,"briefTitle":1580,"status":1581,"phases":1605,"primaryCompletion":1583,"completion":1584,"start":1585,"enrollment":118,"conditions":1606,"interventions":1607},[74],[1587],[1564,1589],{"intervention":330,"totalTrials":574,"cells":1609},{"EARLY_PHASE1":1610,"PHASE1":1612,"PHASE2":1614,"PHASE3":1616,"PHASE4":1618,"NA":1620},{"trials":1611,"activeCount":81},[],{"trials":1613,"activeCount":81},[],{"trials":1615,"activeCount":81},[],{"trials":1617,"activeCount":81},[],{"trials":1619,"activeCount":81},[],{"trials":1621,"activeCount":81},[1622],{"nctId":321,"briefTitle":322,"status":95,"phases":1623,"completion":324,"start":325,"enrollment":326,"conditions":1624,"interventions":1625},[74],[328],[330,41],{"intervention":1627,"totalTrials":574,"cells":1628},"Empagliflozin 25mg",{"EARLY_PHASE1":1629,"PHASE1":1631,"PHASE2":1633,"PHASE3":1635,"PHASE4":1637,"NA":1639},{"trials":1630,"activeCount":81},[],{"trials":1632,"activeCount":81},[],{"trials":1634,"activeCount":81},[],{"trials":1636,"activeCount":81},[],{"trials":1638,"activeCount":81},[],{"trials":1640,"activeCount":81},[1641],{"nctId":1642,"briefTitle":1643,"status":95,"phases":1644,"primaryCompletion":1645,"completion":1645,"start":1646,"enrollment":188,"conditions":1647,"interventions":1649},"NCT03510000","Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin",[74],"2019-11-21","2018-05-15",[1648],"Type1diabetes",[1627],{"intervention":1651,"totalTrials":574,"cells":1652},"Nabilone",{"EARLY_PHASE1":1653,"PHASE1":1655,"PHASE2":1657,"PHASE3":1659,"PHASE4":1661,"NA":1663},{"trials":1654,"activeCount":81},[],{"trials":1656,"activeCount":81},[],{"trials":1658,"activeCount":81},[],{"trials":1660,"activeCount":81},[],{"trials":1662,"activeCount":81},[],{"trials":1664,"activeCount":81},[1665],{"nctId":1666,"briefTitle":1667,"status":1581,"phases":1668,"primaryCompletion":1669,"completion":1670,"start":1671,"enrollment":352,"conditions":1672,"interventions":1674},"NCT03422861","Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients",[74],"2024-09","2024-12","2023-12",[1673],"Inflammatory Bowel Diseases",[1651,1675],"Placebos",{"intervention":1675,"totalTrials":574,"cells":1677},{"EARLY_PHASE1":1678,"PHASE1":1680,"PHASE2":1682,"PHASE3":1684,"PHASE4":1686,"NA":1688},{"trials":1679,"activeCount":81},[],{"trials":1681,"activeCount":81},[],{"trials":1683,"activeCount":81},[],{"trials":1685,"activeCount":81},[],{"trials":1687,"activeCount":81},[],{"trials":1689,"activeCount":81},[1690],{"nctId":1666,"briefTitle":1667,"status":1581,"phases":1691,"primaryCompletion":1669,"completion":1670,"start":1671,"enrollment":352,"conditions":1692,"interventions":1693},[74],[1673],[1651,1675]]